NCT03739307

Brief Summary

This is a five year multi-site, cross sectional, observational study designed to examine chronic pain and pain treatment after moderate to severe TBI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,805

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2019

Typical duration for all trials

Geographic Reach
1 country

13 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 8, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 13, 2018

Completed
6 months until next milestone

Study Start

First participant enrolled

May 20, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

February 8, 2023

Status Verified

February 1, 2023

Enrollment Period

3.4 years

First QC Date

November 8, 2018

Last Update Submit

February 6, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Brief Pain Inventory (BPI)

    The BPI will be used to determine pain intensity as well as interference related to pain. Intensity of pain is rated by participant on a scale of 0 (no pain) to 10 (pain as bad as you can imagine) when the pain is at it's "worst," "least," "average," and "right now." Pain interference is assessed with seven items using a numeric rating scale ranging from 0 (no interference) to 10 (complete interference). Participants are asked to rate how much pain has interfered with general activity, mood, walking ability, normal work, relations with other people, sleep, and enjoyment of life

    Each participant will complete assessment one time during 4 years of data collection

  • painDetect Questionnaire

    This self report survey consists of seven questions about location and quality of neuropathic pain. Scores range from 0-38 with scores above 18 indicating neuropathic pain and higher scores indicating more severity of pain.

    Each participant will complete assessment one time during 4 years of data collection

Secondary Outcomes (3)

  • Post-Traumatic Stress Disorder Checklist-5 (PCL-5)

    Each participant will complete assessment one time during 4 years of data collection

  • Pain Self Efficacy Questionnaire-2 (PSEQ-2)

    Each participant will complete assessment one time during 4 years of data collection

  • Coping Strategies Questionnaire (CSQ)

    Each participant will complete assessment one time during 4 years of data collection

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participants have sustained a moderate to severe TBI and are now being followed at the collaborating centers as part of the TBIMS NDB which is a study collecting observational data after TBI.

You may qualify if:

  • Participants must be enrolled in the TBI Model Systems National Database (TBNIMS NDB) at one of the collaborating sites and thus will meet the TBIMS NDB criteria which are: (1) medical documentation of TBI caused by external mechanical force with either loss of consciousness exceeding 30 minutes, post-traumatic amnesia lasting more than 24 hours, Glasgow Coma Scale score in ER of less than 13, or trauma related intracranial abnormality or neuroimaging abnormalities; (2) admitted to the TBI inpatient rehab program at study sites; and (3) minimum age of 16 \[18 for VA site\]

You may not qualify if:

  • Participants unable to participate in the surveys themselves will not be included (i.e. no proxy surveys).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

University of Alabama

Birmingham, Alabama, 35294, United States

Location

Craig Hospital

Englewood, Colorado, 80113, United States

Location

Tampa VA

Tampa, Florida, 33612, United States

Location

Indiana University

Indianapolis, Indiana, 46202, United States

Location

Spaulding Rehabilitation Institute

Charlestown, Massachusetts, 02129, United States

Location

Wayne State University

Detroit, Michigan, 78202, United States

Location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

New York University School of Medicine

New York, New York, 10016, United States

Location

MOSS Rehabilitation Research Institute

Elkins Park, Pennsylvania, 19027, United States

Location

Baylor Research Institute

Dallas, Texas, 75204, United States

Location

TIRR Memorial Hermann

Houston, Texas, 77030, United States

Location

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

Location

University of Washington

Seattle, Washington, 98195, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticPain

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Co-Principal Investigator

Study Record Dates

First Submitted

November 8, 2018

First Posted

November 13, 2018

Study Start

May 20, 2019

Primary Completion

October 1, 2022

Study Completion

October 1, 2022

Last Updated

February 8, 2023

Record last verified: 2023-02

Locations